Latest news
Loading news…
Calypso Biotech is a biotechnology company that developes therapeutics for autoimmune diseases.
Calypso Biotech was acquired by Novartis in 2024 for $250M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Plan-les-ouates, Geneve, Switzerland
Key People at Calypso Biotech
CEO & Co-founder
CSO & Co-Founder
2
professional contacts at Calypso Biotech
Contact execs at Calypso Biotech →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Calypso Biotech
Loading news…
FAQs about Calypso Biotech
People who checked this page also checked these
Browse the full Acquirezy directory.